Poland
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -28.55 M
|
Dec. 31, 2023 | USD 1.13 | -2.47% |
|
Poland |
|
2 |
USD -23.88 M
|
Dec. 31, 2023 | USD 206.65 | -0.03% |
|
Poland |
|
3 |
USD -18.75 M
|
Dec. 31, 2023 | USD 10.51 | -3.97% |
|
Poland |
|
4 |
USD -11.29 M
|
Dec. 31, 2023 | USD 2.23 | -2.90% |
|
Poland |
|
5 |
USD -11.22 M
|
Dec. 31, 2023 | USD 34.85 | -3.77% |
|
Poland |
|
6 |
USD -11.20 M
|
Sept. 30, 2024 | USD 51.90 | -3.89% |
|
Poland |
|
7 |
USD -11.20 M
|
Dec. 31, 2023 | USD 0.86 | -4.13% |
|
Poland |
|
8 |
USD -9.64 M
|
Dec. 31, 2023 | USD 2.23 | -2.59% |
|
Poland |
|
9 |
USD -8.32 M
|
Dec. 31, 2023 | USD 5.78 | -2.65% |
|
Poland |
|
10 |
USD -8.31 M
|
Dec. 31, 2023 | USD 5.23 | -1.43% |
|
Poland |
|
11 |
USD -8.05 M
|
Dec. 31, 2023 | USD 2.81 | -1.43% |
|
Poland |
|
12 |
USD -8.01 M
|
Dec. 31, 2023 | USD 9.53 | 2.20% |
|
Poland |
|
13 |
USD -4.58 M
|
Dec. 31, 2023 | USD 3.36 | 11.39% |
|
Poland |
|
14 |
USD -2.18 M
|
Dec. 31, 2023 | USD 6.53 | 2.36% |
|
Poland |
|
15 |
USD -1.64 M
|
Dec. 31, 2023 | USD 1.79 | -1.96% |
|
Poland |
|
16 |
USD -894.41 K
|
Dec. 31, 2023 | USD 1.76 | -3.29% |
|
Poland |
|
17 |
USD -762.04 K
|
Dec. 31, 2023 | USD 12.20 | -4.46% |
|
Poland |
|
18 |
USD -489.18 K
|
Dec. 31, 2023 | USD 39.15 | -2.15% |
|
Poland |
|
19 |
USD -116.23 K
|
Dec. 31, 2023 | USD 20.96 | 2.85% |
|
Poland |
|
20 |
USD -79.63 K
|
Dec. 31, 2023 | USD 1.11 | -3.12% |
|
Poland |
|
21 |
USD -44.63 K
|
Dec. 31, 2023 | USD 3.74 | -3.55% |
|
Poland |
|
22 |
USD -19.25 K
|
Dec. 31, 2023 | USD 0.74 | -0.78% |
|
Poland |
The Biotechnology company in Poland with the highest Capital Expenditure is Synthaverse S.A. (Warsaw Stock Exchange: SVE.WA) at USD -28.55 M.
The Biotechnology company in Poland with the lowest Capital Expenditure is NanoGroup S.A. (Warsaw Stock Exchange: NNG.WA) at USD -19.25 K.
The top 10 Biotechnology companies in Poland by Capital Expenditure are Synthaverse S.A., NEUCA S.A., Selvita S.A., Molecure S.A., Voxel S.A., Synektik Spólka Akcyjna, BIOTON S.A., Mabion S.A., Celon Pharma S.A. and Centrum Medyczne ENEL-MED S.A..
The bottom 10 Biotechnology companies in Poland by Capital Expenditure are NanoGroup S.A., Pure Biologics Spólka Akcyjna, Pharmena S.A., Bioceltix S.A., Scope Fluidics S.A., Captor Therapeutics Spolka Akcyjna, Genomtec S.A., Medinice S.A., Ryvu Therapeutics S.A. and BioMaxima S.A..